What Data Are Required to Adopt New Antihypertensive Agents?

The arguments presented in this brief review indicate that despite the large number of antihypertensive agents currently available, there is still need for additional drugs. Introduction of new members of an existing class is justified if the new drug presents advantages in terms of ancillary properties or side effect profile, when compared with other… (More)